The molecular basis for this phenomenon remains incompletely understood, but in fact the ultimate requirement of Menin for KMT2A‐complex integrity seems to be limited to a small number of target genes (including the transcription factor MEIS1) that are particularly essential for leukemia cells, thereby creating an impressive therapeutic index. The gene discussed is MEIS1; the disease is leukemia.